Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health World Mauritania.
Press releases published on September 23, 2025
PathAI Launches Industry-Backed AIM-HI UC Model on GCP-Compliant Platform to Standardize Histological Assessment in Ulcerative Colitis Trials
BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- PathAI, the global leader in AI-powered pathology, today announced the integration of AIM-HI UC1, an advanced AI model for Ulcerative Colitis (UC) histology endpoint assessment, on to AISight™ Clinical Trials, …
Regulatory-grade device evidence reimagined with new precision data from Truveta
BELLEVUE, Wash., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Truveta today announced a major expansion of its real-world device data capabilities, giving device manufacturers and regulators the most complete, clinically rich view of medical device performance ever …
Vitamin K2 Industry Outlook 2029: Demand, Key Players, and Market Dynamics |Europe Leads the Charge in the Booming Market
Delray Beach, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- According to a research report by MarketsandMarkets, the Vitamin K2 Market by Product Type (MK-4, MK-7), Source (Natural Origin, Synthetic Origin), Application Form (Capsules …
X-Chem Launches Chemomics: Applying Omics-Scale Chemistry Data to Yield New Candidate-Quality Molecules
WALTHAM, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- X-Chem, a global leader in data-driven drug discovery, today announced the launch of chemomics: a transformational framework that harnesses the full scale of DNA-encoded library (DEL) technology with …
AAMI Foundation Awards Grants to Hospital, University Research Teams
Arlington, Virginia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- The AAMI Foundation today announces the recipients of the latest group of Mary K. Logan Research Grants. These three university and hospital projects align with the overall mission of the Association …
Shotsy Names Eric Perakslis as Chief Science Officer to Advance Safe, Science-Backed GLP-1 Support
PORTLAND, Ore., Sept. 23, 2025 (GLOBE NEWSWIRE) -- When it comes to GLP-1 weight loss medications, including Ozempic®, Zepbound® and Wegovy®, having access is only part of the equation. Patients need tools to help track their progress, manage side effects …
PridCor Therapeutics Principal Investigator Dr. David Putrino Participates in National Long COVID Roundtable Convened by Secretary Robert F. Kennedy Jr.
TUSCALOOSA, Ala., Sept. 23, 2025 (GLOBE NEWSWIRE) -- PridCor Therapeutics today announced that Dr. David Putrino, principal investigator of the company’s SHIELD Study, participated in a national roundtable on Long COVID convened by U.S. Health and Human …
Silo Pharma Signs Strategic Agreement with Fireblocks to Advance Crypto Treasury Strategy Acquisition and Security
SARASOTA, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that it has engaged Fireblocks, an …
Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity
MIAMI, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced a successful …
FibroBiologics to Present at 2025 Cell & Gene Meeting on the Mesa
HOUSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic …
Aphaia Pharma Publishes Phase 1 and 2 Clinical Data of Oral Formulation in Patients with Obesity and Prediabetes
Aphaia’s lead formulation orchestrates a comprehensive hormonal response from nutrient-sensing cells with potential to modify the course of obesity and associated metabolic diseases. It is currently under evaluation in a Phase 2 trial in individuals with …
Tevogen Highlights Potential Role of TVGN 489 in Eliminating Persistent Viral Reservoirs Linked to Long COVID
WARREN, N.J., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today highlights emerging scientific evidence linking persistent viral reservoirs to Long COVID, and emphasizes the potential of its …
Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System
HINGHAM, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of the innovative LIBERTY® Endovascular Robotic System, announces that its Chief Executive Officer, Harel Gadot, will be interviewed on …
SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children
DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today that preliminary results from the SAVE Surveillance Registry will be presented by SeaStar Medical and its …
IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025
Oral presentation will highlight the results from the randomized Phase 3 trial (IOB-013/KN-D18) of IO102-IO103 cancer vaccine plus pembrolizumab for first-line (1L) advanced melanoma Poster presentation will share final data from Phase 2 basket trial (IOB- …
Julius Clinical Welcomes Bassem Saleh as Chief Executive Officer
Zeist, The Netherlands, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Julius Clinical, a leading clinical Contract Research Organization (CRO) with deep therapeutic expertise in CNS and Cardiometabolic diseases, is pleased to announce the appointment of Bassem Saleh …
Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland
BERKELEY, Calif. and MAINZ, Germany, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, is pleased to announce the …
ALPINE WHITE brings Brazil its first peroxide-free dental whitening strips
RIO DE JANEIRO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ALPINE WHITE, the Swiss oral-care company known for blending science and tradition in innovation, announces the launch in Brazil of its at-home dental-whitening portfolio. Developed in Switzerland, the …
ALPINE WHITE trae a Brasil sus primeras tiras blanqueadoras dentales sin peróxido
RÍO DE JANEIRO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ALPINE WHITE, la empresa suiza de cuidado bucal, conocida por combinar ciencia y tradición en innovación, anuncia el lanzamiento de su variedad de productos para el blanqueamiento dental doméstico en …
ALPINE WHITE traz ao Brasil as primeiras fitas clareadoras dentais sem peróxido
RIO DE JANEIRO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ALPINE WHITE, empresa suíça de cuidado oral reconhecida por unir ciência e tradição em inovação, anuncia o lançamento no Brasil de seu portfólio de clareamento dental para uso caseiro. Desenvolvidas na …